Ola Melin
Chief Operating Officer at CIRCIO HOLDING ASA
Ola Melin active positions
Companies | Position | Start | End |
---|---|---|---|
CIRCIO HOLDING ASA | Chief Operating Officer | - | - |
Corporate Officer/Principal | 01/10/2021 | - |
Career history of Ola Melin
Former positions of Ola Melin
Companies | Position | Start | End |
---|---|---|---|
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | - | - |
SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - | - |
Training of Ola Melin
Mälardalen University | Undergraduate Degree |
Statistics
International
Sweden | 4 |
Norway | 2 |
Operational
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
CIRCIO HOLDING ASA | Health Technology |
Private companies | 1 |
---|---|
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Ola Melin
- Experience